BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With Remix Therapeutics joining forces with Roche and Daiichi 
 Sankyo partnering with Depixus\, there has been many valuable collaborati
 ons entering the RNA-targeting field accelerating efficacious and selecti
 ve small molecules targeting RNA directly\, RNA-binding proteins and RNA/
 protein complexes.\n\nHence\, as the go-to meeting for the RNA-targeting 
 small molecule the community\, the 7th Annual RNA-Targeted Drug Discovery
  and Development Summit returns to Boston this December. Increase your kn
 owledge of RNA tertiary structures\, delve into innovative preclinical mo
 delling strategies and identify optimal chemical features for advancing s
 pecific\, efficacious and safe small molecules.\n\nUnite with 100+ RNA Sc
 ience\, Medicinal Chemistry\, Structural Biology and Biophysics experts f
 rom the likes of AstraZeneca\, Sanofi\, Novartis\, PTC Therapeutics\, Rev
 iR Therapeutics\, Rgenta Therapeutics\, Accent Therapeutics and more at t
 he most comprehensive and definitive event for the community\, the 7th RN
 A-Targeted Drug Discovery and Development Summit\, to accomplish faster a
 nd smoother translation of RNA targeted therapies towards the clinic.\n\n
 &nbsp\;\n\nDate and Time: On Tuesday December 10\, 2024 at 9:00 am to Thu
 rsday December 12\, 2024 at 5:00 pm\n
DTEND:20241212T170000
DTSTAMP:20260512T220829Z
DTSTART:20241210T090000
LOCATION:Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, Massachusett
 s\, 02115\,
SEQUENCE:0
SUMMARY:With Remix Therapeutics joining forces with Roche and Daiichi Sank
 yo partnering with Depixus\, there has been many valuable collaborations 
 entering...
UID:c5b360bd-b0c1-42b5-baff-fd72983d7867
END:VEVENT
END:VCALENDAR